Multicenter phase II study of adding bi-weekly cetuximab to oral S-1 therapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapies
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Interventions: adding bi-weekly cetuximab to oral S-1 therapy Primary outcome(s): Progression free survival Study Design: Single arm Non-randomized
创建时间：
2011-10-15
